Drugs / MK0524A
Trials 7 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 23 trials | ||||||
| Phase 2 | NCT00533312 | Apr → Jul 2005 | hyperlipidemia | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 2 | NCT00536237 | Aug 2004 → Feb 2005 | flushing of ears and somnolence | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 2 | NCT00533676 | Aug 2004 → Dec 2006 | flushing of ears and somnolence | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 34 trials | ||||||
| Phase 3 | NCT00479882 | Jun 2007 → Jun 2008 | hyperlipidemia, combined, 2, hyperlipoproteinemia | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 3 | NCT00533611 | Apr → Aug 2007 | flushing of ears and somnolence | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 3 | NCT00376584 | Jul 2006 → Jan 2007 | hyperlipidemia | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 3 | NCT00289900 | Jan 2006 → Aug 2010 | hyperlipidemia, combined, 2 | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00738985 Comparator | Nov 2009 → Sep 2010 | cardiovascular disorder, hyperlipidemia | National Institute of Medical Sciences and Nutrition Salvador Zubiran | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MK-0524A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00479882 ↗ |